Glucotrack Stock Analysis

GlucoTrack Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.46. Some equities with similar Price to Book (P/B) outperform the market in the long run. GlucoTrack recorded a loss per share of 3442.8. The entity had not issued any dividends in recent years. The firm had 1:60 split on the 16th of June 2025. GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel. Glucotrack operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. To learn more about GlucoTrack call the company at 201 842 7715 or check out https://glucotrack.com.

GlucoTrack Investment Alerts

GlucoTrack Upcoming and Recent Events

GlucoTrack Environmental, Social, and Governance (ESG) Scores

GlucoTrack Thematic Classifications

GlucoTrack Stock Institutional Investors

Note, although GlucoTrack's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

GlucoTrack Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.36 M.

GlucoTrack Profitablity

Management Efficiency

GlucoTrack has return on total asset (ROA) of (1.6101) % which means that it has lost $1.6101 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.9434) %, meaning that it created substantial loss on money invested by shareholders. GlucoTrack's management efficiency ratios could be used to measure how well GlucoTrack manages its routine affairs as well as how well it operates its assets and liabilities. At this time, GlucoTrack's Return On Tangible Assets are quite stable compared to the past year. Return On Assets is expected to rise to 4.00 this year, although the value of Return On Capital Employed is projected to rise to (2.97). At this time, GlucoTrack's Total Current Liabilities is quite stable compared to the past year. Non Current Liabilities Total is expected to rise to about 18.5 M this year, although the value of Liabilities And Stockholders Equity will most likely fall to about 4 M.

Technical Drivers

As of the 19th of July, GlucoTrack retains the Risk Adjusted Performance of (0.03), market risk adjusted performance of (0.22), and Standard Deviation of 8.99. GlucoTrack technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

GlucoTrack Price Movement Analysis

GlucoTrack Insider Trading Activities

GlucoTrack Outstanding Bonds

GlucoTrack Predictive Daily Indicators

GlucoTrack Corporate Filings

GlucoTrack Forecast Models

GlucoTrack's time-series forecasting models are one of many GlucoTrack's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary GlucoTrack's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how GlucoTrack prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling GlucoTrack shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as GlucoTrack. By using and applying GlucoTrack Stock analysis, traders can create a robust methodology for identifying GlucoTrack entry and exit points for their positions.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlucoTrack. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlucoTrack. If investors know GlucoTrack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlucoTrack listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of GlucoTrack is measured differently than its book value, which is the value of GlucoTrack that is recorded on the company's balance sheet. Investors also form their own opinion of GlucoTrack's value that differs from its market value or its book value, called intrinsic value, which is GlucoTrack's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlucoTrack's market value can be influenced by many factors that don't directly affect GlucoTrack's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between GlucoTrack's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlucoTrack is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlucoTrack's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.